Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33836578.
- Also identified by DOI 10.1073/pnas.2016580118 and PMC identifier 7980282.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Human adaptive-like "memory" CD56<sup>dim</sup>CD16<sup>+</sup> natural killer (NK) cells in peripheral blood from cytomegalovirus-seropositive individuals have been extensively investigated in recent years and are currently explored as a treatment strategy for hematological cancers. However, treatment of solid tumors remains limited due to insufficient NK cell tumor infiltration, and it is unknown whether large expansions of adaptive-like NK cells that are equipped for tissue residency and tumor homing exist in peripheral tissues. Here, we show that human lung and blood contains adaptive-like CD56<sup>bright</sup>CD16<sup>-</sup> NK cells with hallmarks of tissue residency, including expression of CD49a. Expansions of adaptive-like lung tissue-resident NK (trNK) cells were found to be present independently of adaptive-like CD56<sup>dim</sup>CD16<sup>+</sup> NK cells and to be hyperresponsive toward target cells. Together, our data demonstrate that phenotypically, functionally, and developmentally distinct subsets of adaptive-like NK cells exist in human lung and blood. Given their tissue-related character and hyperresponsiveness, human lung adaptive-like trNK cells might represent a suitable alternative for therapies targeting solid tumors.
Medical subject headings
- Killer Cells, Natural
- Lung